Control of the estradiol-induced prolactin surge by the suprachiasmatic nucleus

Endocrinology. 2001 Jun;142(6):2296-302. doi: 10.1210/endo.142.6.8219.

Abstract

In the present study we investigated how the suprachiasmatic nucleus (SCN) controls the E(2)-induced PRL surge in female rats. First, the role of vasopressin (VP), a SCN transmitter present in medial preoptic area (MPO) projections and rhythmically released by SCN neurons, as a circadian signal for the E(2)-induced PRL surge was investigated. Using a reverse microdialysis technique, VP was administered in the MPO during the PRL surge, resulting in a suppression of the surge. VP administration before the surge did not affect PRL secretion. Also, administration of a V1a receptor antagonist before the surge was ineffective. Second, lesions of the SCN were made that resulted in constant basal PRL levels, suggesting that with removal of the SCN a stimulatory factor for PRL secretion disappeared. Indeed, the PRL secretory response to blockade of pituitary dopamine receptors was significantly reduced in SCN-lesioned animals. These data suggest that the afternoon decrease of VP release in the MPO by SCN terminals enables the PRL surge to occur, and may thus be a circadian signal for the PRL surge. Simultaneously the SCN is involved in the regulation of the secretory capacity of the pituitary, possibly via specific PRL-releasing factors.

MeSH terms

  • Animals
  • Circadian Rhythm
  • Drug Implants
  • Estradiol / administration & dosage
  • Estradiol / pharmacology*
  • Female
  • Microdialysis
  • Ovariectomy
  • Preoptic Area / drug effects
  • Preoptic Area / physiology
  • Proestrus
  • Prolactin / metabolism*
  • Rats
  • Rats, Wistar
  • Suprachiasmatic Nucleus / physiology*
  • Suprachiasmatic Nucleus / surgery
  • Vasopressins / metabolism
  • Vasopressins / pharmacology

Substances

  • Drug Implants
  • Vasopressins
  • Estradiol
  • Prolactin